1 MONTELUKAST SODIUM | 440 of 2850 | 2000 prescriptions Less than 1% of all prescriptions | 1590 | 380 patients 16% of all patients | < 11 | |
2 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 800 of 2630 | 1090 prescriptions Less than 1% of all prescriptions | 910 | 240 patients 10% of all patients | < 11 | |
3 SPIRIVA (TIOTROPIUM BROMIDE) | 740 of 2770 | 840 prescriptions Less than 1% of all prescriptions | 700 | 180 patients 8% of all patients | < 11 | |
4 PROAIR HFA (ALBUTEROL SULFATE) | 550 of 2780 | 1080 prescriptions Less than 1% of all prescriptions | 910 | 350 patients 15% of all patients | < 11 | |
5 PREDNISONE | 790 of 2970 | 1500 prescriptions Less than 1% of all prescriptions | 1210 | 580 patients 25% of all patients | < 11 | |
6 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 540 of 2260 | 710 prescriptions Less than 1% of all prescriptions | | 170 patients 7% of all patients | < 11 | |
7 VENTOLIN HFA (ALBUTEROL SULFATE) | 1080 of 3050 | 940 prescriptions Less than 1% of all prescriptions | 530 | 370 patients 16% of all patients | < 11 | |
8 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 1300 of 2970 | 680 prescriptions Less than 1% of all prescriptions | | 210 patients 9% of all patients | < 11 | |
9 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 940 of 2720 | 520 prescriptions Less than 1% of all prescriptions | 370 | 130 patients 6% of all patients | < 11 | |
10 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 680 of 2300 | 650 prescriptions Less than 1% of all prescriptions | 410 | 170 patients 7% of all patients | < 11 | |
11 PANTOPRAZOLE SODIUM | 240 of 880 | 390 prescriptions Less than 1% of all prescriptions | | 120 patients 5% of all patients | < 11 | |
12 FLUTICASONE PROPIONATE | 710 of 2470 | 380 prescriptions Less than 1% of all prescriptions | 190 | 130 patients 6% of all patients | < 11 | |
13 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 190 of 1190 | 500 prescriptions Less than 1% of all prescriptions | | 120 patients 5% of all patients | < 11 | |
14 FUROSEMIDE | 270 of 1130 | 410 prescriptions Less than 1% of all prescriptions | | 170 patients 7% of all patients | < 11 | |
15 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 400 of 1330 | 270 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 1120 of 2430 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 OFEV (NINTEDANIB ESYLATE) | 240 of 700 | 250 prescriptions Less than 1% of all prescriptions | 250 | < 11 | < 11 | |
18 AZITHROMYCIN | 960 of 2430 | 270 prescriptions Less than 1% of all prescriptions | | 130 patients 6% of all patients | < 11 | A |
19 AZELASTINE HCL | 250 of 570 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 DALIRESP (ROFLUMILAST) | 570 of 1390 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 310 of 760 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
22 XARELTO (RIVAROXABAN) | 100 of 350 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
23 FLOVENT HFA (FLUTICASONE PROPIONATE) | 530 of 1410 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
24 ELIQUIS (APIXABAN) | 160 of 420 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
25 ESBRIET (PIRFENIDONE) | 300 of 700 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
26 OMEPRAZOLE | 630 of 1720 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
27 METHYLPREDNISOLONE | 330 of 420 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
28 LEVOFLOXACIN | 340 of 1220 | 260 prescriptions Less than 1% of all prescriptions | | 240 patients 10% of all patients | < 11 | A |
29 DOXYCYCLINE HYCLATE | 430 of 960 | 200 prescriptions Less than 1% of all prescriptions | | 180 patients 8% of all patients | < 11 | A |
30 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 350 of 860 | 140 prescriptions Less than 1% of all prescriptions | | 120 patients 5% of all patients | < 11 | A |